Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Zomedica Pharmaceuticals Corp (ZOM.VN)

Zomedica Pharmaceuticals Corp (ZOM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 30,791
  • Shares Outstanding, K 128,872
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 0.20
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ZOM.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings $-0.03 on N/A
  • Latest Earnings Date 02/25/20
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.03
  • Number of Estimates 1
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +75.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.285 unch
on 02/05/20
0.450 -36.67%
on 01/27/20
-0.155 (-35.23%)
since 12/23/19
3-Month
0.285 unch
on 02/05/20
0.500 -43.00%
on 12/02/19
-0.235 (-45.19%)
since 09/27/19
52-Week
0.285 unch
on 02/05/20
1.500 -81.00%
on 02/25/19
-1.415 (-83.24%)
since 01/11/19

Most Recent Stories

More News
Sean Whelan Appointed to Board of Directors

ANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

ZOM.VN : 0.285 (-6.56%)
DPLO : 4.00 (+0.25%)
ZOM : 0.1301 (-0.08%)
Zomedica Announces Second Quarter 2021 Financial Results

TRUFORMA® Instrument Placement Program Implemented to Incentivize Future Assay Sales

ZOM.VN : 0.285 (-6.56%)
ZOM : 0.1301 (-0.08%)
Zomedica Announces 2021 Annual Meeting Results

ANN ARBOR, Mich., July 30, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp.  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

ZOM.VN : 0.285 (-6.56%)
ZOM : 0.1301 (-0.08%)
Zomedica Provides Corporate Update

FOCUSED ON TRUFORMA ® INSTRUMENT PLACEMENTS AND BUILDING DIRECT SALES ORGANIZATION

ZOM.VN : 0.285 (-6.56%)
ZOM : 0.1301 (-0.08%)
Zomedica Hires Vice President Business Development to Lead Acquisition and Licensing Efforts

Former Elanco Animal Health, Johnson & Johnson, Intuitive Surgical, and Enteromedics Business Development Executive Joins Team to Support Growth Opportunities

ZOM.VN : 0.285 (-6.56%)
ZOM : 0.1301 (-0.08%)
Zomedica Announces First Quarter 2021 Financial Results

ANN ARBOR, Mich, May 12, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp.  (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary health company creating point-of-care diagnostics products for...

ZOM.VN : 0.285 (-6.56%)
ZOM : 0.1301 (-0.08%)
Zomedica to Build Direct Sales Force for TRUFORMA® Platform

ANN ARBOR, Mich., April 15, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp.  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

ZOM.VN : 0.285 (-6.56%)
ZOM : 0.1301 (-0.08%)
Zomedica Announces First Commercial Sale of Its Truforma® Platform

ANN ARBOR, Mich., March 16, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp.  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

ZOM.VN : 0.285 (-6.56%)
QRVO : 114.70 (+2.27%)
ZOM : 0.1301 (-0.08%)
Zomedica Retires Preferred Shares

TRUFORMA® Progressing Toward Commercialization

ZOM.VN : 0.285 (-6.56%)
ZOM : 0.1301 (-0.08%)
Zomedica Corp. Announces Year End 2020 Financial Results

ANN ARBOR, Mich., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

ZOM.VN : 0.285 (-6.56%)
ZOM : 0.1301 (-0.08%)

Business Summary

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. It provides...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.285
1st Resistance Point 0.285
Last Price 0.285
1st Support Level 0.285
2nd Support Level 0.285
3rd Support Level N/A

See More

52-Week High 1.500
Fibonacci 61.8% 1.036
Fibonacci 50% 0.892
Fibonacci 38.2% 0.749
Last Price 0.285
52-Week Low 0.285

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar